Naumann Bd

Setting health-based residue limits for contaminants in pharmaceuticals and medical devices.

Conine Dl, Naumann Bd, Hecker Lh, 1992 .

Performance-based exposure control limits for pharmaceutical active ingredients.

B D Naumann, E V Sargent, B S Starkman, 1996, American Industrial Hygiene Association journal.